Mar 1
|
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation?
|
Feb 28
|
Cytek Biosciences Inc (CTKB) Q4 2024 Earnings Call Highlights: Strong International Growth and ...
|
Feb 27
|
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates
|
Feb 27
|
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
|
Jan 15
|
Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
|
Jan 2
|
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
|
Dec 30
|
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
|
Aug 8
|
Cytek Biosciences to Participate in Upcoming Investor Conferences
|
Aug 8
|
Cytek Biosciences Second Quarter 2024 Earnings: Misses Expectations
|
Aug 6
|
Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue Estimates
|
Aug 6
|
Cytek Biosciences Reports Second Quarter 2024 Financial Results
|
Jul 30
|
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
|
Jul 30
|
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
|
Jun 24
|
Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?
|
May 13
|
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript
|
May 10
|
Cytek Biosciences Inc (CTKB) Q1 2024 Earnings: Revenue Surges, Yet Net Loss Persists
|
May 9
|
Cytek Biosciences Inc (CTKB) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
|
May 8
|
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates
|
May 8
|
Cytek Biosciences Reports First Quarter 2024 Financial Results
|
Apr 30
|
Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know
|